Norfloxacin
- Generic Name
- Norfloxacin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C16H18FN3O3
- CAS Number
- 70458-96-7
- Unique Ingredient Identifier
- N0F8P22L1P
- Background
A synthetic fluoroquinolone (fluoroquinolones) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA gyrase.
- Indication
For the treatment of urinary tract infection
- Associated Conditions
- Cystitis, Gonococcal cervicitis, Infectious diarrhea, Pyelitis, Pyelonephritis, Spontaneous Bacterial Peritonitis (SBP), Traveler's Diarrhea, Urethritis gonococcal
- Associated Therapies
- -
A Pilot Study of Norfloxacin for Hepatopulmonary Syndrome
- First Posted Date
- 2006-08-10
- Last Posted Date
- 2016-12-07
- Lead Sponsor
- Unity Health Toronto
- Target Recruit Count
- 9
- Registration Number
- NCT00362752
- Locations
- 🇨🇦
St. Michael's Hospital, Toronto, Ontario, Canada
Vasoactive Peptides in Portal Pressure
Not Applicable
- Conditions
- First Posted Date
- 2005-09-14
- Last Posted Date
- 2007-07-26
- Lead Sponsor
- Bayside Health
- Registration Number
- NCT00163982
- Locations
- 🇦🇺
Alfred Hospital, Melbourne, Victoria, Australia
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath